MCB
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Docheva, D.
Right arrow Articles by Brandau, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Docheva, D.
Right arrow Articles by Brandau, O.
Molecular and Cellular Biology, January 2005, p. 699-705, Vol. 25, No. 2
0270-7306/05/$08.00+0     doi:10.1128/MCB.25.2.699-705.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Tenomodulin Is Necessary for Tenocyte Proliferation and Tendon Maturation

Denitsa Docheva,1 Ernst B. Hunziker,2 Reinhard Fässler,1* and Oliver Brandau1,{dagger}

Department of Molecular Medicine, Max Planck Institute for Biochemistry, Martinsried, Germany,1 ITI Research Institute, University of Berne, Berne, Switzerland2

Received 15 October 2004/ Accepted 26 October 2004

Tenomodulin (Tnmd) is a member of a new family of type II transmembrane glycoproteins. It is predominantly expressed in tendons, ligaments, and eyes, whereas the only other family member, chondromodulin I (ChM-I), is highly expressed in cartilage and at lower levels in the eye and thymus. The C-terminal extracellular domains of both proteins were shown to modulate endothelial-cell proliferation and tube formation in vitro and in vivo. We analyzed Tnmd function in vivo and provide evidence that Tnmd is processed in vivo and that the proteolytically cleaved C-terminal domain can be found in tendon extracts. Loss of Tnmd expression in gene targeted mice abated tenocyte proliferation and led to a reduced tenocyte density. The deposited amounts of extracellular matrix proteins, including collagen types I, II, III, and VI and decorin, lumican, aggrecan, and matrilin-2, were not affected, but the calibers of collagen fibrils varied significantly and exhibited increased maximal diameters. Tnmd-deficient mice did not have changes in tendon vessel density, and mice lacking both Tnmd and ChM-I had normal retinal vascularization and neovascularization after oxygen-induced retinopathy. These results suggest that Tnmd is a regulator of tenocyte proliferation and is involved in collagen fibril maturation but do not confirm an in vivo involvement of Tnmd in angiogenesis.


* Corresponding author. Mailing address: Max Planck Institute for Biochemistry, Department of Molecular Medicine, Am Klopferspitz 18, 82152 Martinsried, Germany. Phone: 49-89-8578-2424. Fax: 49-89-8578-2422. E-mail: faessler{at}biochem.mpg.de.

{dagger} Present address: Department of Physiology, LMU-München, 80336 Munich, Germany.


Molecular and Cellular Biology, January 2005, p. 699-705, Vol. 25, No. 2
0022-538X/05/$08.00+0     doi:10.1128/MCB.25.2.699-705.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2005 by the American Society for Microbiology. All rights reserved.